• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子相互作用、小鼠与机制:亨廷顿舞蹈症的新见解

Of molecular interactions, mice and mechanisms: new insights into Huntington's disease.

作者信息

Wellington C L, Hayden M R

机构信息

Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.

出版信息

Curr Opin Neurol. 1997 Aug;10(4):291-8. doi: 10.1097/00019052-199708000-00003.

DOI:10.1097/00019052-199708000-00003
PMID:9266152
Abstract

Huntington's disease is caused by expansion of a CAG trinucleotide beyond 35 repeats within the coding region of a novel gene. Recently, new insights into the relationship between CAG expansion in the HD gene and pathological mechanisms have emerged. These include a more precise understanding of the relationship between CAG repeat length and age of onset, progress in transgenic and excitotoxic animal models, identification of a novel huntington-interacting protein, and intriguing connections between huntington and the apoptotic machinery. We have combined many of these new findings into a model that suggests mechanisms and predicts outcomes by which the pathogenesis of Huntington's disease may be initiated. The development of appropriate in-vitro and animal models for Huntington's disease will allow the validity of this model to be tested.

摘要

亨廷顿舞蹈症是由一个新基因编码区域内的CAG三核苷酸重复序列扩展至35次以上所引起的。最近,对于亨廷顿舞蹈症(HD)基因中CAG重复序列扩展与病理机制之间的关系有了新的认识。这些认识包括对CAG重复序列长度与发病年龄之间关系的更精确理解、转基因和兴奋性毒性动物模型方面的进展、一种新型亨廷顿相互作用蛋白的鉴定,以及亨廷顿蛋白与凋亡机制之间引人关注的联系。我们将其中许多新发现整合到一个模型中,该模型提出了亨廷顿舞蹈症发病机制可能启动的机制并预测了结果。开发合适的亨廷顿舞蹈症体外和动物模型将使该模型的有效性得到检验。

相似文献

1
Of molecular interactions, mice and mechanisms: new insights into Huntington's disease.分子相互作用、小鼠与机制:亨廷顿舞蹈症的新见解
Curr Opin Neurol. 1997 Aug;10(4):291-8. doi: 10.1097/00019052-199708000-00003.
2
Toward understanding the molecular pathology of Huntington's disease.迈向对亨廷顿舞蹈症分子病理学的理解。
Brain Pathol. 1997 Jul;7(3):979-1002. doi: 10.1111/j.1750-3639.1997.tb00897.x.
3
[Huntington's disease: clinical and molecular genetics].[亨廷顿舞蹈症:临床与分子遗传学]
Nihon Rinsho. 1999 Apr;57(4):896-9.
4
[Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].[三核苷酸重复扩增数目在亨廷顿舞蹈病临床表现中的重要性]
Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82.
5
Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.在突变型亨廷顿舞蹈病基因的小鼠基因敲入模型中,出现了年龄依赖性和组织特异性的CAG重复序列不稳定性。
J Neurosci Res. 2001 Aug 15;65(4):289-97. doi: 10.1002/jnr.1153.
6
Recent advances in understanding the pathogenesis of Huntington's disease.亨廷顿舞蹈症发病机制研究的最新进展
Trends Neurosci. 1999 Jun;22(6):248-55. doi: 10.1016/s0166-2236(99)01415-0.
7
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.具有225个CAG重复序列的新型亨廷顿舞蹈病BAC小鼠模型表现出早期广泛且稳定的退化表型。
J Huntingtons Dis. 2015;4(1):17-36.
8
Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.R6/2小鼠中由超长CAG重复序列扩增导致的疾病发病出现反常延迟。
Neurobiol Dis. 2009 Mar;33(3):331-41. doi: 10.1016/j.nbd.2008.11.015. Epub 2008 Dec 11.
9
A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.一种基于CAG长度预测亨廷顿舞蹈病发病年龄和外显率的新模型。
Clin Genet. 2004 Apr;65(4):267-77. doi: 10.1111/j.1399-0004.2004.00241.x.
10
Advances in Huntington's disease: implications for experimental therapeutics.亨廷顿舞蹈症的研究进展:对实验性治疗的启示
Curr Opin Neurol. 1998 Aug;11(4):357-62. doi: 10.1097/00019052-199808000-00012.

引用本文的文献

1
Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity.钙蛋白酶介导的蛋白水解作为多聚谷氨酰胺毒性的驱动因素和调节因子。
Front Mol Neurosci. 2022 Oct 19;15:1020104. doi: 10.3389/fnmol.2022.1020104. eCollection 2022.
2
Gene Alterations Induced by Glutamine (Q) Encoding CAG Repeats Associated with Neurodegeneration.谷氨酰胺(Q)编码 CAG 重复诱导的基因突变与神经退行性变有关。
Methods Mol Biol. 2023;2575:3-23. doi: 10.1007/978-1-0716-2716-7_1.
3
A pathogenic proteolysis-resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function.
一种由反义寡核苷酸诱导的致病性、抗蛋白水解的亨廷顿蛋白异构体可维持亨廷顿蛋白的功能。
JCI Insight. 2022 Sep 8;7(17):e154108. doi: 10.1172/jci.insight.154108.
4
Calpains as novel players in the molecular pathogenesis of spinocerebellar ataxia type 17.钙蛋白酶在脊髓小脑共济失调 17 型的分子发病机制中的新作用
Cell Mol Life Sci. 2022 Apr 28;79(5):262. doi: 10.1007/s00018-022-04274-6.
5
A Novel Calpain Inhibitor Compound Has Protective Effects on a Zebrafish Model of Spinocerebellar Ataxia Type 3.一种新型钙蛋白酶抑制剂化合物对脊髓小脑共济失调 3 型斑马鱼模型具有保护作用。
Cells. 2021 Sep 29;10(10):2592. doi: 10.3390/cells10102592.
6
From pathways to targets: understanding the mechanisms behind polyglutamine disease.从信号通路到靶点:理解多聚谷氨酰胺疾病背后的机制。
Biomed Res Int. 2014;2014:701758. doi: 10.1155/2014/701758. Epub 2014 Sep 21.
7
Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?复杂性与异质性:是什么驱动亨廷顿舞蹈症中不断变化的大脑?
Ann N Y Acad Sci. 2008 Dec;1147:196-205. doi: 10.1196/annals.1427.034.
8
Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.聚谷氨酰胺调节的YAC转基因亨廷顿病小鼠模型纹状体钙蛋白酶活性:对NMDA受体功能和毒性的影响
J Neurosci. 2008 Nov 26;28(48):12725-35. doi: 10.1523/JNEUROSCI.4619-08.2008.
9
Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.尽管体内存在广泛的神经元亨廷顿蛋白包涵体,但未出现行为异常和神经退行性变。
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11402-7. doi: 10.1073/pnas.0503634102. Epub 2005 Aug 2.
10
The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.蛋白水解和核定位在多聚谷氨酰胺疾病毒性中的作用。综述。
Neurotox Res. 2005;7(1-2):43-57. doi: 10.1007/BF03033775.